A Single-volunteer Study of Immune Response Following OTS-412 Vaccinia Virus Systemic Injection(Self-experiment)

Phase 0 Completed 1 enrolled Bionoxx Inc.

NaSingle-groupOpen-labelBasic science

Summary

Following oncolytic virus (OV) administration, the host immune response is initiated immediately and evolves dynamically. However, in clinical OV therapy, it is virtually impossible to capture these immune events in real time. To address this gap, the principal investigator conducted a high-resolution immune monitoring study in a healthy volunteer.

Timeline

Start: 2022-01-04
Primary completion: 2022-01-14
Completion: 2022-05-02

Drugs

Evaluation	Drug	Modality	Dose	Route
Subject	OTS-412	Unknown	—	—

Indications

No indication recorded.